CHICAGO--GE HealthCare (Nasdaq: GEHC) announced today 510(k) clearance of three new magnetic resonance (MR) innovations with ...
GE HealthCare Technologies Inc. GEHC recently announced FDA 510(k) clearance for three new magnetic resonance (MR) ...
The FDA clearance of GE HealthCare’s next-generation Signa products aligns with the company’s multi-year strategy to ...
CHICAGO--(BUSINESS WIRE)--GE Healthcare today announced the launch of SIGNA Experience, a platform of four synergistic technologies that help users through the diagnostic journey. This integrated ...
CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min GE HealthCare’s Waukesha-based ...
Through GE Healthcare's AI Innovation Lab, Mass General Brigham and UW-Madison will pair the company's magnetic resonance imaging foundational model with real data from their hospital systems and then ...
SAN FRANCISCO—GE HealthCare is launching a new imaging research collaboration with the University of California, San Francisco, aimed at improving the diagnosis of neurodegenerative diseases and ...
The FDA cleared the Signa Sprint with Freelium, Signa Bolt and Signa One. Signa Sprint is a 1.5T sealed magnet MRI system, while Signa Bolt is an advanced 3T MRI scanner. Signa One offers an AI-driven ...